The Role of Early Period ERCP in Acute Biliary Pancreatitis?

Serdar ASLAN, (Bahçelievler Anıtı Hastanesi Genel Müdürlüğü, Cerrahi, İstanbul,Türkiye)
Kemal PEKER, (Düzce Üniversitesi, Genel Cerrahi Bölümü, Düzce, Türkiye)
Mehmet İlhan YILDIRGAN (Atatürk Üniversitesi, Genel Cerrahi Bölümü, Erzurum, Türkiye)
KONURALP TIP DERGİSİ
1 0
Yıl: 2021 Cilt: 13 Sayı: 2 Sayfa Aralığı: 242 - 250 Metin Dili: İngilizce DOI: 10.18521/ktd.749787 İndeks Tarihi: 06-12-2021

The Role of Early Period ERCP in Acute Biliary Pancreatitis?

Öz:
Objective: Acute pancreatitis;It can be defined as a clinical picture that occurs as a result ofnon_bacterial inflammation of the pancreas and may progress with pathological findings. Foryears, various studies have been conducted on the use of Endoscopic RetrogradeCholangiopancreotography and Endoscopic Sphincterotomy for therapeutic purpose in AcutePancreatitis. For years, various studies have been conducted on the use of EndoscopicRetrograde Cholangiopancreotography and Endoscopic Sphincterotomy for therapeuticpurpose in Acute Pancreatitis.In our study, we aimed to examine either the effectiveness of Endoscopic RetrogradeCholangiopancreotography and Endoscopic Sphincterotomy in patients with mild severity,and how the endoscopic procedure affects the course of the disease.Methods: In this study, patients with mild pancreatitis were selected among the patients whoapplied to the Department of General Surgery, of Atatürk University Faculty of Medicine anddiagnosed with acute biliary pancreatitis (ABP).After the patients were separated according to the mild pancreatitis, early (within 72 hours)and late period, they were randomly selected to be performed Endoscopic RetrogradeCholangiopancreotography and Endoscopic Sphincterotomy. 59 patients were detected in thisway.Results: Twelve (20.3%) of the patients included in our study were male, and 47 (79.7%)were female, and their ages were between 25-75 years (mean 64.3 years). Two groups werecreated in order to perform ERCP/ES in the early and late periods. All patients had acuteonset abdominal pain and serum amylase levels have been ranging between (1012-7660UI/L).Conclusions: In patients with mild acute biliary pancreatitis, there is no significant differencein the early (first 72 hours) ERCP/ES results compared to the results of patients withERCP/ES in the late period.
Anahtar Kelime:

Akut Bilier Pankreatitte Erken Dönem ERCP’nin Rolü?

Öz:
Amaç: Akut pankreatit; Pankreasın bakteriyel olmayan enflamasyonu sonucu patolojikbulgularla seyredebilen klinik bir tablo olarak tanımlanabilir. Yıllardan beri EndoskopikRetrograd Kolanjiopankreatikografi ve Endoskopik Sfinkterotomi’nin Akut Pankreatit’deterapötik maksatlı olarak kullanımı ile ilgili çeşitli çalışmalar yapılmaktadır. Bu çalışmalaragöre özellikle hafif şiddetli Akut Pankreatit’de erken Endoskopik RetrogradKolanjiopankreatikografi ve Endoskopik Sfinkterotomi tartışmalı olmaya devam etmektedir.Biz çalışmamızda hafif şiddetteki Akut Pankreatit’li hastalarında, Endoskopik RetrogradKolanjiopankreatikografi ve Endoskopik Sfinkterotomi’nin tedavideki etkinliğini, aynızamanda yapılan endoskopik işlemin hastalığın seyrini nasıl etkilediğini araştırmayıamaçladık.Gereç ve Yöntem: Bu çalışmada, Atatürk Üniversitesi Tıp Fakültesi Genel Cerrahi AnabilimDalına, akut bilier pankreatit (ABP) tanısı ile müracaat eden hastalar arasından, Ransonkriterleri ve hastaların klinik durumlarına göre hafif şiddetteki pankreatitli hastalar belirlendi.Hastalar hafif pankreatit tablosuna göre ayrıldıktan sonra erken (72 saat içinde) ve geçdönemde, Endoskopik Retrograd Cholangiopancreotography ve Endoskopik Sfinkterotomiyapılmak üzere randomize bir şekilde seçildi. Bu şekilde 59 hasta tespit edildi. Bulgular: Çalışmamıza dahil edilen hastaların 12’si (%20,3 ) erkek, 47’si (%79,7) kadınolup, yaşları 25–75 yıl (ortalama 64,3 yıl) idi. Hastalara erken ve geç dönemde ERCP/ESyapılmak üzere 2 grup oluşturuldu. Hastaların 24(%40,6)’üne erken 35(%59,4)’ine geçdönemde ERCP/ES yapıldı. Tüm hastalarda akut başlayan karın ağrısı vardı ve serum amilazseviyeleri (1012-7660 Üİ/L) arasında değişmekte idi.Sonuç: Hafif şiddetteki akut bilier pankreatitli hastalarda erken (ilk 72 saat)ERCP/ESsonuçlarının geç dönemde ERCP/ES yapılan hastaların sonuçları ile karşılaştırıldığındaanlamlı bir fark yoktur. Bu nedenle hafif şiddetteki akut bilier pankreatitli hastalara erkendönemde ERCP/ES yapılabileceği kanaatindeyiz
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Leung PS. Overview of the pancreas. Adv Exp Med Biol. 2010;690:3-12.
  • 2. Walsh MK. Diagnosis, prognosis, and treatment of acute pancreatitis. Am Fam Physician. 2008;77(5):594.
  • 3. Portelli M, Jones CD. Severe acute pancreatitis: Pathogenesis, diagnosis and surgical management. Hepatobiliary Pancreat Dis Int. 2017;16(2):155-59.
  • 4. Büchler MW, Gloor B, Müller CA, Friess H, Seiler CA. Uhl W. Acute necrotizing pancreatitis: Treatment strategy according to the status of infection. Ann Surg. 2000;232:619–26.
  • 5. van Santvoort HC, Besselink MG, de Vries AC, Boermeester MA, Fischer K, Bollen TL, et al. Early endoscopic retrograde cholangiopancreatography in predicted severe acute biliary pancreatitis: A prospective multicenter study. Ann Surg. 2009;250(1):68-75.
  • 6. Rosseland AR, Solhaug JH. Early or delayed endoscopic papillotomy (EPT) in gallstone pancreatitis. Ann. Surg. 1984;199(2):165-7.
  • 7. Alfred DR, Ira MJ. Evaluation of the pattern of liver tests and yield of cholangiography in symptomatic choledocholitiasis. Gastrointestinal Endoscopy. 1997;45:394-9.
  • 8. Dursun M, Yılmaz Ş, Canoru F, Batum S, Kaplan A. Akut pankreatitli olgularımızın analizi. Dicle Tıp Dergısi. 2001;28(2):19-27.
  • 9. Naruse, S. Molecular pathophysiology of pancreatitis. Internal Medicine. 2003;42(3): 288-9.
  • 10. Ergüney S, Çiçek Y. Tıkanma sarılığı endoskopik tedavi. In: Hutcheon DF, Kafonek DR. trans. Güncel BY. Cerrahi tedavi. İstanbul: Avrupa Tıp Kitapçılık Ltd. Şti.; 2001. p. 477-80.
  • 11. Lin C, Simon L, Bruce ES, Roger JL, Katayoun T, Christian V. Preoperative versus postoperative endoscopic retrograde cholangiopancreatography in mild to moderate gallstone pancreatitis: A prospective randomized trial. Annals of Surgery. 2000;231(1):82–7.
  • 12. Stefan H, Markus S, Valentin R, Pierre-Alain C. Evidence-based treatment of acute pancreatitis: A look at established paradigms. Ann Surg. 2006;243(2):154–68.
  • 13. Nomura T, Shirai Y, Wakai T, Yokoyama N, Sakata J, Hatakeyama K. Narrow portion of the terminal choledochus is a cause of upstream biliary dilatation in patients with anomalous union of the pacreatic and biliary ducts. Wold J Gastroenterol. 2005;11(41):6503-7.
  • 14. Yuk-Pang Y, Siu-Fai L, Andrew Wai-Chun Y. Role of ERCP in the management of predicted mild acute biliary pancreatitis. Asian J Surg. 2003;26(4):197–201.
  • 15. Mikó A, Vigh É, Mátrai P, Soós A, Garami A, Balaskó M, et al. Computed tomography severity index vs. other indices in the prediction of severity and mortality in acute pancreatitis: A predictive accuracy meta- analysis. Front Physiol. 2019;10:1002.
  • 16. Poves P, Fabregat P, García B, Jorba M, Figueras F, Jaurrieta M. Early onset of organ failure is the best predictor of mortality in acute pancreatitis. Rev Esp Enferm Dig. 2004;96:705-13.
  • 17. Aranda-Narváez JM, González-Sánchez AJ, Montiel-Casado MC, Titos-García A, Santoyo-Santoyo. J. Acute necrotizing pancreatitis: Surgical indications and technical procedures. World J Clin Cases. 2014;2(12):840-5.
  • 18. Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2010;2010(5):CD002941.
  • 19. Zhou YM, Xue ZL, Li YM, Zhu YQ, Cao N. Antibiotic prophylaxis in patients with severe acut pancreatitis. Hepatobiliary Pancreat Dis Int. 2005;4(1):23‐7.
  • 20. Bassi C, Larvin M, Villatoro E. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2003;(4):CD002941.
  • 21. William HN, John B, Eric MW. Appropriate timing of cholecystectomy in patients who present with moderate to severe gallstone-associated acute pancreatitis with peripancreatic fluid collections. Ann Surg. 2004;239(6):741–51.
  • 22. Jan JDW, Eric H, Stijn IB, Johan D, Francis C. Intra-abdominal hypertension in patients with severe acute pancreatitis. Critical Care. 2005;9(4): 452–7.
  • 23. Siregar GA, Siregar GP. Management of severe acute pancreatitis. Maced J Med Sci. 2019;7(19):3319-23.
  • 24. Ai-Jun Z, Jing-Sen S, Xue-Jun S. Organ failure associated with severe acute pancreatitis. World J Gastroenterol. 2003;9(11):2570-3.
  • 25. Alberto M. Pharmacological prevention of post-ercp pancreatitis: Which therapy is best? JOP. J Pancreas. 2003;4:68-74.
  • 26. Matull WR, Pereira SP, O'Donohue JW. Biochemical markers of acute pancreatitis. J Clin Pathol. 2006;59(4):340-4.
  • 27. Moggia E, Koti R, Belgaumkar AP, Fazio F, Pereira SP, Davidson BR, et al. Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev. 2017;4(4):CD011384. 28. Tarnasky PR. Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indications JOP. J Pancreas. 2003;4:58-67.
  • 29. Thomas R, Eckhart GH. Post-ERCP pancreatitis: Is the Endoscopist ́s experience the major risk factor? JOP. J Pancreas. 2002;3:177-87.
  • 30. Hookey LC, RioTinto R, Delhaye M, Baize M, Le Moine O, Devière J. Risk factors for pancreatitis after pancreatic sphincterotomy: A review of 572 cases. Endoscopy. 2006;38(7):670-6.
  • 31. Andriulli A, Caruso N, Quitadamo M, Forlano R, Leandro G, Spirito F, et al. Antisecretory vs. antiproteasic drugs in the prevention of post-ercp pancreatitis: The evidence-based medicine derived from a meta-analysis study. JOP. 2003;4(1):41-8.
  • 32. Turan M, Karadayı K, Duman M, Koyuncu A, Aydın C, Topçu Ö, et al. Endoskopik retrograd kolanjiopankreatografi deneyimimiz. C. Ü. Tıp Fakültesi Dergisi. 2003;25:171–6.
  • 33. Acosta JM, Katkhouda N, Debian KA, Groshen SG, Tsao-Wei DD, Berne TV. Early ductal decompression versus conservative management for gallstone pancreatitis with ampullary obstruction. Ann Surg. 2006;243:33–4.
  • 34. Sugiyama M, Suzuki Y, Abe N, Masaki T, Mori T, Atomi Y. Endoscopic retreatment of recurrent choledocholithiasis after sphincterotomy. Gut. 2004;53(12):1856-9.
  • 35. Ming–Qing Z, Neng PL, Ren-Da L. Doudenoscopy in treatment of acute gallstone pancreatitis. Hepatobiliary and Pancreatic Disseases International. 2002;1:608-10.
  • 36. Freeman ML. Post-ercp pancreatitis: Patient and technique-related risk factors jop. J Pancreas. 2002;3:169-76.
  • 37. Stapfer M, Selby RR, Stain SC, Katkhouda N, Parekh D, Jabbour N, et al. Management of duodenal perforation after endoscopic retrograde cholangiopancreatography and sphincterotomy. Annals of Surgery. 2000;232:191–8.
  • 38. García-Cano L, González M, Ariño M, Sola PA. Complications of endoscopic retrograde cholangiopancreatography. A study in a small ERCP unit. Rev Esp Enferm Dig. 2004;96:163-73.
  • 39. Thompson BF, Wilcox AM. Antibiotic prophylaxis prior to endoscopic retrograde cholangiopancreatography in patients with obstructive jaundice: Is it worth the cost? Aliment Pharmacol Ther. 2002;16(4):727-34.
  • 40. Masadeh M, Chandra S, Livorsi D, Johlin F, Silverman W. Evaluation of biliary bacterial resistance in patients with frequent biliary instrumentation, one size does not fit all. Dig Dis Sci. 2018;63(12):3474-9.
  • 41. Kwak MS, Jang ES, Ryu JK, Kim YT, Yoon YB, Park JK. Risk factors of post endoscopic retrograde cholangiopancreatography bacteremia. Gut Liver. 20137(2):228-33.
  • 42. Schneider J, Hapfelmeier A, Fremd J, Schenk P, Obermeier A, Burgkart R, et al. Biliary endoprosthesis: A prospective analysis of bacterial colonization and risk factors for sludge formation. PLoS One. 2014;9(10): e110112.
  • 43. Xiong GS, Wu SM, Zhang XW. Clinical trial of gabexate in theprophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. Braz J Med Biol Res. 2006;39(1):85-90.
  • 44. Poon RTP, Yeung C, Liu CL, Lam CM, Yuen WK, Lo CM, et al. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: A randomised controlled trial. Gut. 2003;52:1768-73.
  • 45. Lai KH, Lo GH, Cheng JS, Fu MT, Wang EM, Chan HH, et al. Effect of somatostatin on the sphincter of Oddi in patients with acute non-biliary pancreatitis. Gut. 2001;49:843-6.
  • 46. Sandberg AA, Borgström A. Early prediction of severity in acute pancreatitis. Is this possible? JOP. 2002;3(5):116-25.
  • 47. Macsi E, Cavallini G, Mariani A, Frulloni L, Testoni PA, Curioni S, et al. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis. American Journal of Gastroenterology. 2003;98(10):2182-6.
  • 48. Xiong GS, Wu SM, Zhang XW, Ge ZZ. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. Braz J Med Biol Res. 2006;39:85-90.
  • 49. Bistritz L, Bain VG. Sphincter of Oddi dysfunction: Managing the patient with chronic biliary pain. World J Gastroenterol. 2006;28:3793-3802.
  • 50. Sherman S, Lehman GA. Sphincter of Oddi dysfunction: Diagnosis and treatment JOP. J. Pancreas. 2001;2:382-400.
  • 51. Del Vecchio Blanco G, Gesuale C, Varanese M, Monteleone G, Paoluzi OA. Idiopathic acute pancreatitis: a review on etiology and diagnostic work-up. Clin J Gastroenterol. 2019;12(6):511-24.
  • 52. Cahen DL, van Berkel AM, Oskam D, Rauws EA, Weverling GJ, Huibregtse K, et al. Long-term results of endoscopic drainage of common bile duct strictures in chronic pancreatitis. Eur J Gastroenterol Hepatol. 2005;17(1):103-8.
  • 53. Madhav B, Fei LW, Yang CH, Yen LJ, Huang PP, Lakshmi C. Pathophysiology of acute pancreatitis. Pancreatology. 2005;5(2-3):132–44.
  • 54. Gürleyik G, Emir S, Kiliçoglu G, Arman A, Saglam A. Computed tomography severity index, APACHE II score and serum CRP concentration for predicting the severity of acute pancreatitis JOP. J Pancreas. 2005;6:562-7.
  • 55. Milewski J, Rydzewska G, Degowska M, Kierzkiewicz M, Rydzewski A. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. World J Gastroenterol. 2006;12(23):3751-5.
  • 56. Catani M, De Milito R, Battillocchi B, Citone G, Ricciardulli T, Romagnoli F, et al. Therapeutic and diagnostic protocol for mild acute biliary pancreatitis: our experience and review of the literature. Chir Ital. 2008;60(1):47-54.
  • 57. Chong VH, Yim HB, Lim CC. Endoscopic retrograde cholangiopancreatography in the elderly: Outcomes, safety and complications. Singapore Med J. 2005;46(11):621-6.
  • 58. Kohut M, Nowak A, Nowakowska-Dulawa E, Marek T. Presence and density of common bile duct microlithiasis in acute biliary pancreatitis. World J Gastroenterol. 2002;8:558-61.
APA Aslan S, Peker K, YILDIRGAN M (2021). The Role of Early Period ERCP in Acute Biliary Pancreatitis?. , 242 - 250. 10.18521/ktd.749787
Chicago Aslan Serdar,Peker Kemal,YILDIRGAN Mehmet İlhan The Role of Early Period ERCP in Acute Biliary Pancreatitis?. (2021): 242 - 250. 10.18521/ktd.749787
MLA Aslan Serdar,Peker Kemal,YILDIRGAN Mehmet İlhan The Role of Early Period ERCP in Acute Biliary Pancreatitis?. , 2021, ss.242 - 250. 10.18521/ktd.749787
AMA Aslan S,Peker K,YILDIRGAN M The Role of Early Period ERCP in Acute Biliary Pancreatitis?. . 2021; 242 - 250. 10.18521/ktd.749787
Vancouver Aslan S,Peker K,YILDIRGAN M The Role of Early Period ERCP in Acute Biliary Pancreatitis?. . 2021; 242 - 250. 10.18521/ktd.749787
IEEE Aslan S,Peker K,YILDIRGAN M "The Role of Early Period ERCP in Acute Biliary Pancreatitis?." , ss.242 - 250, 2021. 10.18521/ktd.749787
ISNAD Aslan, Serdar vd. "The Role of Early Period ERCP in Acute Biliary Pancreatitis?". (2021), 242-250. https://doi.org/10.18521/ktd.749787
APA Aslan S, Peker K, YILDIRGAN M (2021). The Role of Early Period ERCP in Acute Biliary Pancreatitis?. KONURALP TIP DERGİSİ, 13(2), 242 - 250. 10.18521/ktd.749787
Chicago Aslan Serdar,Peker Kemal,YILDIRGAN Mehmet İlhan The Role of Early Period ERCP in Acute Biliary Pancreatitis?. KONURALP TIP DERGİSİ 13, no.2 (2021): 242 - 250. 10.18521/ktd.749787
MLA Aslan Serdar,Peker Kemal,YILDIRGAN Mehmet İlhan The Role of Early Period ERCP in Acute Biliary Pancreatitis?. KONURALP TIP DERGİSİ, vol.13, no.2, 2021, ss.242 - 250. 10.18521/ktd.749787
AMA Aslan S,Peker K,YILDIRGAN M The Role of Early Period ERCP in Acute Biliary Pancreatitis?. KONURALP TIP DERGİSİ. 2021; 13(2): 242 - 250. 10.18521/ktd.749787
Vancouver Aslan S,Peker K,YILDIRGAN M The Role of Early Period ERCP in Acute Biliary Pancreatitis?. KONURALP TIP DERGİSİ. 2021; 13(2): 242 - 250. 10.18521/ktd.749787
IEEE Aslan S,Peker K,YILDIRGAN M "The Role of Early Period ERCP in Acute Biliary Pancreatitis?." KONURALP TIP DERGİSİ, 13, ss.242 - 250, 2021. 10.18521/ktd.749787
ISNAD Aslan, Serdar vd. "The Role of Early Period ERCP in Acute Biliary Pancreatitis?". KONURALP TIP DERGİSİ 13/2 (2021), 242-250. https://doi.org/10.18521/ktd.749787
Sayfa Oluşturulma Tarihi
24-04-2024 18:21

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları